Biogen's Early-Stage Alzheimer's Data Continues to Impress Post author:Sam Post published:November 1, 2017 Post category:BioPharma ALZ’s researchers continue to see hope in Biogen’s aducanumab. Source: BioSpace You Might Also Like Ocular Therapeutix to Slash Jobs After FDA Rejection August 1, 2017 ReachBio LLC Celebrates 10 Years In Business September 11, 2017 Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
